Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1116 results about "Cardiac arrhythmia" patented technology

Wireless biological monitoring device and system

SOLUTION: To provide a cardiac monitoring system and a method for using such a system, in which preferable embodiments of the system and method detecting cardiac information through a wearable device and then recording the same, and extracting data features from the recorded cardiac information, the extracted data features being analyzed and used for clinical diagnosis.EFFECT: A biological monitoring system can smooth and / or enhance patient experience, for achieving more precise and timely diagnosis of cardiac arrhythmia.SELECTED DRAWING: Figure 11
Owner:IRHYTHM TECHNOLOGIES INC

Non-invasive cardiac monitor and method for inferring or predicting a patient's physiological characteristics - Patents.com

The present disclosure relates to a non-invasive cardiac monitoring device that records cardiac data to infer the onset of a human physiological characteristic, such as the onset of cardiac arrhythmia, and recommends treatment / intervention. Some embodiments include clustering patient data history to determine efficacy of treatment based on cluster groups corresponding to the patient data. In further embodiments, processing of detected cardiac heart rate signals can be partially processed in the wearable cardiac monitoring device and partially processed in a remote computing system. Some embodiments include a wearable cardiac monitoring device that is attached to a patient for extended periods of time to enable long-term detection of cardiac heart rate signals.
Owner:IRHYTHM TECHNOLOGIES INC

Extended reality (XR) applications for cardiac arrhythmia procedures

Novel tools and techniques are provided for implementing intelligent assistance (“IA”) ecosystem, and, in some cases, for implementing extended reality (“XR”) for cardiac arrhythmia procedures. In various embodiments, a computing system might receive device data associated with a device(s) configured to perform a cardiac arrhythmia procedure to provide effective heart rhythm, might receive imaging data associated with an imaging device(s) configured to generate images of a portion(s) of a patient. The computing system might analyze the received device data and imaging data (collectively “received data”), might map the received data to a 3D or 4D representation of the portion(s) of the patient based on the analysis, and might generate and present (using a user experience (“UX”) device) one or more XR images or experiences based on the mapping.
Owner:MEDTRONIC INC

Sleep monitoring method and system based on combination of electroencephalogram and millimeter wave radar

The invention relates to the technical field of sleep monitoring, in particular to a sleep monitoring method and system based on combination of electroencephalogram and millimeter wave radar, and aims to solve the problem that OSA judgment accuracy is insufficient due to complication. The method comprises the following steps: acquiring an electroencephalogram signal of a user based on a wireless EEG sensor, and acquiring a physiological signal of the user by using a millimeter wave radar; performing sleep staging analysis on the electroencephalogram signal, and detecting a micro-awakening event in combination with body movement data; the physiological signals are processed through a physiological signal processing model, physiological signal features of the user are extracted, and an apnea event, a hypopnea event, an arrhythmia event, a blood pressure fluctuation abnormal event and a periodic leg movement event of the user are monitored; calculating each OSA judgment index according to the event; and calculating OSA personalized scores according to the OSA judgment indexes, performing OSA severity grading, and generating an OSA severity grading report for assisting medical staff in diagnosis and treatment scheme formulation.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Compounds and methods for reducing PLN expression

Provided are oligomeric compounds, methods, and pharmaceutical compositions for reducing the amount or activity of PLN RNA in a cell or animal, and in certain instances reducing the amount of phospholamban protein in a cell or animal. Such oligomeric compounds, methods, and pharmaceutical compositions are useful to treat cardiomyopathy, heart failure, or arrhythmia.
Owner:IONIS PHARMACEUTICALS INC

Delivery plan evaluation system

System and methods are described for developing a delivery plan for a pulsed field ablation device for treating an arrhythmia. A method runs a lesion development simulation based on cardiac characteristics and a treatment plan that specifies a delivery plan and a target location to generate a simulated lesion having lesion characteristics. The method initializes a three-dimensional (3D) mesh representing a heart based on cardiac characteristics. The vertices of the 3D mesh are associated with cardiac tissue characteristics with some of the associated with cardiac tissue characteristics representing an arrhythmia source. The method adjusts the cardiac tissue characteristics of vertices of the 3D mesh to reflect the effect of an ablation resulting in formation of the simulated lesion. The method runs a lesion evaluation simulation based on the 3D mesh with the adjusted cardiac tissue characteristics to determine whether the simulated lesion would be effective at treating the arrhythmia.
Owner:THE VEKTOR GRP INC

Electrode apparatus for diagnosis of arrhythmias

A method comprising shaping and joining three loop members of a catheter is disclosed herein. The method includes coupling proximal ends of each loop member to a distal portion of an elongated shaft and overlapping the first loop member, the second loop member, and the third loop member at a common distal vertex such that when the first, second, and third loop members are unconstrained, at least one of the loop members is non-coplanar with one or both of the other loop members and when the shaft is manipulated to press the loop members to a planar surface, a majority of each loop member is moved to contact the planar surface.
Owner:BIOSENSE WEBSTER (ISRAEL) LTD

Electrode apparatus for diagnosis of arrhythmias

An apparatus includes an end effector having loop members with electrodes thereon and is usable with catheter-based systems to measure or provide electrical signals. The end effector can include three loop members that are non-coplanar when expanded unconstrained that become contiguous to a planar surface when the loop members are deflected against the surface, a mechanical linkage that joins the loop members at a distal vertex of the end effector, electrodes having surface treatment to enhance surface roughness of the electrodes, twisted pair electrode wires, a bonded spine cover, and / or any combination thereof.
Owner:BIOSENSE WEBSTER (ISRAEL) LTD

Multi-label arrhythmia identification method based on multi-branch residual attention network

The invention discloses a multi-label arrhythmia identification method based on a multi-branch residual attention network, and relates to the technical field of ECG classification, and the method comprises the steps: carrying out the preprocessing of original data, including resampling and segmentation; constructing a training set, a verification set and a test set for network model training; inputting the processed training set into a multi-branch residual network for training, extracting information of different scales by different branch feature extractors, further automatically obtaining electrocardio features by using a residual attention module through fusion branches, and testing and storing an optimal target model in a verification set; and predicting on a test set, comparing with a label, and calculating the accuracy rate and recall rate of arrhythmia classification. According to the method, multi-label arrhythmia detection is carried out by using a thought of combining a multi-branch network and residual attention, so that the classification precision and the prediction accuracy are improved.
Owner:HANGZHOU PROTON TECH CO LTD

Acute assessment of cardiac ablatoin lesions

Devices, systems and methods are provided for treating conditions of the heart, particularly the occurrence of arrhythmias, more particularly atrial fibrillation. Therapeutic pulsed electric field energy is delivered to portions the heart to provide tissue modification, particularly to the entrances to the pulmonary veins in the treatment of atrial fibrillation. Such tissue modification creates a lesion or series of lesions which act as a conduction block within the tissue to prevent the transmission of aberrant electrical signals. Cardiovascular lesion analysis systems and methods provide information related to the effectiveness of the treatment during the procedure so as to create an electrical blockade within the heart that will remain durable and effective long-term.
Owner:CARDIOFOCUS INC

Rapid identification method applied to defibrillation requirement of AED device

The invention discloses a rapid identification method applied to defibrillation requirements of an AED device, and belongs to the technical field of medical equipment. According to the method, multiple links including acquisition, preprocessing, feature extraction, mode classification, real-time classification and defibrillation triggering work cooperatively, and advanced signal classification and mode recognition technologies are introduced, so that efficient and accurate electrocardiosignal analysis is realized in the AED device, the response speed and accuracy in the emergency treatment process are remarkably improved, and the emergency treatment efficiency is improved. Multi-dimensional features of electrocardiosignals are extracted and input into a pattern classification model, automatic recognition of arrhythmia is achieved, whether defibrillation operation needs to be carried out or not can be accurately judged, the possibility of misjudgment is reduced, self-optimization can be carried out according to new electrocardiosignal data through a dynamic learning and retraining mechanism, and the accuracy of defibrillation is improved. The adaptive capacity to a complex heart rhythm mode is improved, the first-aid response time is effectively shortened, the safety of a patient is guaranteed, and the first-aid efficiency and the treatment effect are improved.
Owner:CMICS MEDICAL INSTR CO LTD

Deep learning sudden cardiac death survival prediction

Computer-implemented neural network techniques for predicting patient-specific arrhythmic sudden cardiac death survival are presented. The techniques can include obtaining cardiac image data for a patient; obtaining cardiac covariate data for the patient; providing the cardiac image data to a first subnetwork; providing the cardiac covariate data to a second subnetwork; combining an output from the first subnetwork with an output from the second subnetwork to produce survival probability data; and outputting patient-specific arrhythmic sudden cardiac death survival prediction data based on the survival probability data.
Owner:JOHNS HOPKINS UNIVERSITY

Convolutional neural network information processing system and method for heart function dynamic monitoring

The invention discloses a convolutional neural network information processing method for heart function dynamic monitoring, and belongs to the technical field of medical detection and monitoring. Comprising the following steps that multi-mode electrocardiosignal data and current physiological state parameters of a patient are obtained, and initial configuration of the intelligent heart function monitoring device is obtained; determining the signal quality grade of each signal channel, and generating a dynamic filtering adjustment strategy of the multi-modal signal acquisition module; configuring a feature extraction strategy of a double-branch convolutional neural network module based on the signal features of the target analysis signal segment and the physiological state parameters; performing multi-scale time sequence feature extraction and frequency domain autonomic nerve regulation feature extraction on the target analysis signal segment by using a double-branch convolutional neural network module according to a feature extraction strategy; executing arrhythmia classification, heart rate variability parameter quantification, heart function evaluation grade and graded early warning tasks, and outputting multi-stage intelligent early warning information from normal monitoring, potential risk and abnormal early warning to an emergency state.
Owner:XINYANG NORMAL UNIVERSITY

Device and method for privacy-preserving ECG data collection for arrhythmia classification

Disclosed is a privacy-preserving electrocardiogram (ECG) data collecting method for arrhythmia classification. The privacy-preserving ECG data collecting method is performed by a computing device including at least a processor and includes training a feature extraction model, a personal identification model, and an arrhythmia classification model using learning data that includes ECG data with a predetermined length; and training a noise model, and the feature extraction model receives the ECG data as input and outputs ECG features, the personal identification model receives the ECG features as input and identifies an individual corresponding to the ECG features, the arrhythmia classification model receives the ECG features as input and classifies arrhythmia corresponding to the ECG features, and the noise model generates noise with the same length as that of the ECG features.
Owner:KOREA UNIV RES & BUSINESS FOUND

Multi-label arrhythmia detection method based on multi-scale space-time dynamic graph convolution

The invention discloses a multi-label arrhythmia detection method based on multi-scale space-time dynamic graph convolution, and the method comprises the steps: capturing the space-time feature information of an ECG signal through series gating time convolution and dynamic graph convolution; a feature fusion module is provided, the single-scale representation capability is enhanced through statistical feature assisted global-local feature fusion, redundant information is successfully removed through orthogonal gating multi-scale fusion, and a gating mechanism dynamically adjusts the importance of each scale feature in the feature screening process, so that the accuracy of the feature screening is improved. The sending end and the receiving end are added to further filter information, so that the risks of multi-scale feature overfitting and information loss are effectively avoided, the robustness and accuracy of the model are improved, and the situation that the most valuable information is not fully reserved during multi-scale spatial-temporal feature fusion due to the fact that redundant features are difficult to effectively distinguish in a traditional method is avoided. The method not only improves the accuracy and stability of the model, but also has high practicability, and can effectively support automatic diagnosis of arrhythmia.
Owner:ZHEJIANG SCI-TECH UNIV +3

Arrhythmia classification method and device based on multi-mode diffusion model, and medium

The invention relates to the technical field of interdisciplinary research of biomedicine and computer science, and relates to an arrhythmia classification method and device based on a multi-modal diffusion model, and a medium. The method comprises the steps that input original electrocardiosignals are preprocessed, and three kinds of modal data are generated to serve as training set data; a personalized arrhythmia classification model is constructed; freezing diffusion driving feature extractor parameters, performing personalized optimization on training set data, inputting the data into a personalized arrhythmia classification model, and training the module; the method comprises the following steps: collecting an electrocardiosignal to be detected, preprocessing the electrocardiosignal into three modals of a time domain waveform, a short-time Fourier transform spectrogram and a Lorentz scatter diagram, and carrying out personalized optimization; and inputting the optimized data into the trained personalized arrhythmia classification model to obtain a classification result. According to the invention, high-precision, low-label-dependence and individual-adaptive arrhythmia judgment is realized.
Owner:SHANDONG UNIV

Wearable optical physiological monitoring device adhesion

The present invention relates to a non-invasive cardiac monitoring device that records cardiac data to infer a physiological characteristic of a person, such as arrhythmia or other vital signs. Some examples of the invention allow for long-term monitoring of physiological signals. Other examples allow for processing ECG data and PPG data to calculate pulse time of arrival. Some examples include a wearable cardiac monitoring device on the chest including ECG and PPG sensors for long term attachment to a mammal to detect cardiovascular signals for a long term.
Owner:IRHYTHM TECHNOLOGIES INC

Application of MYZAP overexpression vector in preparation of medicine for preventing and treating MIRI

The invention relates to application of an MYZAP overexpression vector in preparation of a medicine for preventing and treating MIRI, and belongs to the technical field of biological medicine. In order to solve the problem that application of gene drugs in prevention and treatment of myocardial ischemia reperfusion injury is limited, the invention provides application of an MYZAP gene overexpression recombinant vector in preparation of drugs for prevention and treatment of myocardial ischemia reperfusion injury, and the MYZAP gene overexpression recombinant vector is an adeno-associated virus vector AAV9-MYZAP for overexpressing MYZAP. Experiments prove that MYZAP overexpression can improve the cardiac function after myocardial ischemia reperfusion, reduce the occurrence rate of arrhythmia and improve the functions of sodium ion channels, potassium ion channels and calcium ion channels of myocardial cells. On the basis, the invention further provides a medicine for preventing and treating myocardial ischemia reperfusion injury, a new strategy is provided for gene therapy of myocardial ischemia reperfusion injury, and the medicine has a wide clinical application prospect.
Owner:HARBIN MEDICAL UNIVERSITY

Methods for treating and ameliorating angina, myocardial infarction, reperfusion injury, heart arrhythmias and congestive heart failure (CHF)

PCT designated stage expiredWO2025030135A2Heterocyclic compound active ingredientsReperfusion injuryAngina
In alternative embodiments, provided are methods for treating, ameliorating, lessening the symptoms of, or preventing, angina, myocardial infarction, reperfusion injury, ventricular arrhythmias (VA), pump failure due to myocardial infarction (MI) in an early ischemia / reperfusion (I / R) period, and / or congestive heart failure (CHF) comprising administering to an individual in need thereof a composition or a drug capable of suppressing hypoxia-induced SUMOylation of the cardiac sodium channel NaV1.5.
Owner:RGT UNIV OF CALIFORNIA

An artificial intelligence enabled wearable ECG skin patch to detect sudden cardiac arrest

There is described an artificial intelligence wearable ECG skin patch (400) to detect sudden cardiac arrest. The wearable ECG monitoring patch (400) with AI based predictive analytics and remote based cardiac monitoring (615) system that can detect cardiac arrhythmias automatically in real-time and make a diagnosis with AI models trained with acquired data. The wearable skin has a biocompatible polymer patch (400) which captures the electrical signal through a flexible printed electronic technology based conducting ink and a substrate. The microcontroller controls (201), store and transmit the data packets. The IoT connected signal transmission is capable of recording and transferring the data packets through wireless communication. The AI engine is capable of analysing, evaluating, testing and providing the data packets of sudden cardiac arrest through a peak detector algorithm. The ECG skin patch (400) to detect and measure the sudden cardiac arrest with the R-R interval time series to obtain heart rate variability.
Owner:TOPIA LIFE SCI LTD

Systems and methods for presenting arrhythmia episodes

Systems and methods for managing machine-generated alert notifications of medical events detected from one or more patients are described herein. An embodiment of a data management system may receive an adjudication of a medical event episode including an episode characterization. A storage unit stores an association between one or more episode characterizations and corresponding detection algorithms for detecting a medical event having respective episode characterizations. An episode management circuit may detect from a subsequent episode, using the stored association, a medical event having an episode characterization of at least one medical event episode presented for adjudication, and schedule presenting at least a portion of the subsequent episode based on the detection.
Owner:CARDIAC PACEMAKERS INC

Ginsenoside hydrogen sulfide donor derivative as well as preparation method and application thereof

ActiveCN119119162Agood protective activityOrganic active ingredientsSteroidsHeart protectionCardiac arrhythmia
The invention discloses a ginsenoside hydrogen sulfide donor derivative as well as a preparation method and application thereof, and belongs to the technical field of natural medicines and medicinal chemistry. According to the invention, a series of ginsengenin hydrogen sulfide donor derivatives are designed and synthesized by taking ginsengenin as a lead compound, and the myocardial protection activity of the synthesized derivatives is tested; results show that the ginsenoside hydrogen sulfide donor derivative prepared by the invention has relatively good heart protection activity for treating myocardial ischemia, arrhythmia and myocardial infarction, and has the potential of serving as a heart protection medicine.
Owner:SHENYANG PHARMA UNIV

Control method and system for balloon counterpulsation system in aorta

The invention provides a control method and system of an in-aorta balloon counterpulsation system, and relates to the technical field of medical system control. According to the method provided by the invention, through the pre-trained neural network model, the target cardiac cycle of the target user can be quickly and accurately determined according to the historical electrocardiogram monitoring data of the target user under the condition that the target user has arrhythmia or the electrocardiogram signal quality is poor; according to the embodiment of the invention, the target cardiac cycle of the IABP system is obtained, and then inflation and deflation control of the air bag of the IABP system is realized according to the target cardiac cycle, compared with a mode of controlling the IABP system through electrocardio triggering in related technologies, the method provided by the embodiment of the invention can effectively improve the safety and effectiveness of the IABP system, and the use risk of a user is reduced.
Owner:WUHAN LUOJIA PHARMACEUTICAL INTELLIGENT TECHNOLOGY RESEARCH INSTITUTE CO LTD

Application of MYZAP overexpression recombinant vector in preparation of medicine for preventing and treating arrhythmia

The invention relates to application of an MYZAP overexpression recombinant vector in preparation of a medicine for preventing and treating arrhythmia, and belongs to the technical field of biological medicines. In order to solve the problem that application of gene drugs in prevention and treatment of arrhythmia after myocardial infarction is limited, the invention provides application of a myocardial microbelt adhesion protein MYZAP overexpression recombinant vector in preparation of drugs for prevention and treatment of arrhythmia, and the MYZAP overexpression recombinant vector is an adeno-associated virus vector AAV9-MYZAP of an overexpression MYZAP gene. In-vivo experiments prove that MYZAP overexpression can reduce the occurrence of arrhythmia after myocardial infarction by increasing the content of MYZAP protein in cardiac myocardial cells, and improve cardiac functions and cardiac electrical conduction disorders after myocardial infarction. On the basis, the invention further provides a medicine for preventing and treating arrhythmia after myocardial infarction, a new strategy is provided for gene therapy of arrhythmia after myocardial infarction, and the medicine has a wide clinical application prospect.
Owner:HARBIN MEDICAL UNIVERSITY

Apparatus, systems, and methods for optimizing delivery of radiation to treat cardiac arrhythmias

Apparatus, systems, and methods are provided for optimizing radiation therapy to a patient to treat cardiac arrhythmias. The system generally includes an ultrasound device placed within the esophagus to image and map cardiac structures in real-time. The system may also control the ventilation of the patient to optimize ultrasound monitoring and radiation delivery. The device in the esophagus is designed to position and monitor the esophagus and / or nearby structures to optimize radiation delivery to targets while minimizing radiation to other key structures. In addition, different ablation technologies may be delivered from within the esophagus to ablate certain tissues that cannot be safely ablated with radiation therapy. Finally, the esophageal device may have electrical or magnetic properties that can be used to guide the radiation therapy.
Owner:ABLATION INNOVATIONS LLC

Arrhythmia classification method based on multi-scale space-time learning and adaptive selection neural network

The invention provides an arrhythmia classification method based on multi-scale space-time learning and an adaptive selection neural network. Aiming at the problems that electrocardiosignals have different complex wave band information of various scales, pathological changes have the characteristics of transience and intermittency in time sequence, and different channels in space contain different pathological change information, a multi-scale thought is introduced in the invention to extract the complex wave band information; a multi-scale sparse time sequence attention module is designed to capture local tight and remote sparse time sequence feature information, a multi-scale residual convolution module is designed to interact and integrate spatial feature information in different channels, and an adaptive selection module is designed to dynamically select different scales and time steps. In some public data sets, the method has better classification performance and higher diagnosis speed.
Owner:BEIJING UNIV OF TECH

Ultrahigh heart rate electrocardio acquisition system

The invention discloses an ultra-high heart rate electrocardio acquisition system, which comprises a signal acquisition unit adopting an ADS131E08 chip and supporting 8 channels, a 24-bit delta-sigma ADC (Analog to Digital Converter) and programmable gain amplification; the dynamic sampling rate adjusting unit is used for dynamically adjusting the sampling rate between 1kSPS and 64kSPS according to the heart rate change, and the sampling rate is increased to be greater than or equal to 2kSPS when the heart rate exceeds 200 times per minute; a low-noise design circuit has a common-mode rejection ratio greater than or equal to 110dB, a dynamic range greater than or equal to 118dB and total harmonic distortion less than or equal to-90dB, and power frequency interference is suppressed; the morphological enhancement module is used for enhancing QRS wave group characteristics by using digital morphological filtering; the multi-lead fusion module is used for fusing multi-lead signals through time sequence alignment and R-wave phase difference analysis; and the anti-interference module is integrated with a hardware comparator, and is used for lead falling detection and dynamic digital notch filtering. The system is suitable for researches on myocardial ischemia, arrhythmia and drug cardiotoxicity. Compared with the prior art, the device has the advantages of being simple in structure, low in cost, high in precision, high in reliability and the like, and can effectively solve the problem of animal ultrahigh heart rate electrocardio collection.
Owner:DAWEI MEDICAL (JIANGSU) CO LTD

Long-sequence electrocardiosignal disease recognition system based on Transform architecture

The invention relates to the technical field of electrocardiosignal analysis, and discloses a long-sequence electrocardiosignal disease recognition system based on a Transform architecture. The core defects that in traditional electrocardiogram analysis, waveform integrity is damaged by fixed window segmentation, a lead space topological relation is neglected, and long sequence modeling efficiency is low are overcome, a P-QRS-T waveform structure is completely reserved through the heart beat adaptive segmentation technology, and the fixed window truncation risk is eliminated; the lead anatomical topology and the space-time coding are fused, and multi-lead electrophysiological association is modeled; long sequence efficient processing is realized based on hierarchical sparse Transform, and the recognition sensitivity of complex pathologies such as arrhythmia and myocardial ischemia is improved; in combination with gradient directional regulation and control and a streaming processing mechanism, the clinical real-time requirement is met while the diagnosis accuracy is guaranteed, and finally, reliable, efficient and universal intelligent decision support is provided for early warning of heart diseases through lightweight deployment of an adaptive mobile terminal.
Owner:CHINA UNIV OF GEOSCIENCES (BEIJING)

Heart wall refinement of arrhythmia source locations

PCT designated stage expiredWO2025029981A1Medical simulationMedical data miningIrregular heart rhythmCardiac wall
A method for localizing the source of an arrhythmia within a heart wall is disclosed. The method involves accessing an indication of the source location of the arrhythmia within the endocardium. A normal vector is generated that is normal to the endocardium at the source location in the direction of the epicardium layer. An activation vector indicating the direction of electrical force of the heart during an initial stage of depolarization is determined. The depth angle between the normal vector and the activation vector is determined, and the depth of the source location within the heart wall is indicated based on a depth angle.
Owner:THE VEKTOR GRP INC +2

Abnormal heart beat detection method and system based on magnetocardiogram

The invention discloses an abnormal heart beat detection method and system based on a magnetic cardiogram, and relates to the technical field of medical data processing, and the method comprises the steps: carrying out the preprocessing of original magnetic cardiogram data; magnetic cardiogram features are extracted based on discrete wavelet transform, model parameters are adjusted, and an abnormal heart beat detection model is obtained; and judging whether abnormal heart beat exists or not and the position. According to the method, the problem that the magnetocardiogram data lacks a large number of heart beat level labeling samples is effectively solved, dependence on labeling data is reduced, automatic, efficient and accurate detection of abnormal heart beats is achieved, the good clinical application prospect is achieved, and powerful support can be provided for early screening, auxiliary diagnosis and risk assessment of arrhythmia.
Owner:BEIHANG UNIV